Showing 1341-1350 of 3460 results for "".
DERM2024 Meeting Wrap-Up
https://practicaldermatology.com/conferences/derm2024/derm2024-meeting-wrap/26974/DERM2024 Meeting Wrap-UpCurrents: Patient Engagement And Adherence
https://practicaldermatology.com/topics/practice-management/currents-patient-engagement-and-adherence/23500/A Practical Approach to Home UVB Phototherapy for the Treatment of Generalized Psoriasis
https://practicaldermatology.com/topics/psoriasis/a-practical-approach-to-home-uvb-phototherapy-for-the-treatment-of-generalized-psoriasis/21926/Specialists review the basics of choosing ideal patients for home UVB, delineate key aspects of patient education, and provide detailed information on currently available phototherapy equipment.Currents: Win the Adherence Game: Don't Leave Patient Outcomes to Chance
https://practicaldermatology.com/topics/practice-management/win-the-adherence-game/20538/Don't leave patient outcomes to chanceAcne and Rosacea Awareness: Clinician Perspectives
https://practicaldermatology.com/topics/acne-rosacea/acne-and-rosacea-awareness-clinician-perspectives/23927/Key ways to improve treatment outcomes for patients with rosacea and acne.Biosimilars: What's Coming for Labeling?
https://practicaldermatology.com/topics/practice-management/biosimilars-whats-coming-for-labeling/20934/The public comment period on draft labeling guidance will end next month.Vitamin D and Psoriasis
https://practicaldermatology.com/topics/practice-management/vitamin-d-and-psoriasis/21470/New findings suggest a relationship between psoriasis and vitamin D deficiency, but larger details are still unknown.The Cornyism of Cronyism
https://practicaldermatology.com/topics/practice-management/the-cornyism-of-cronyism/23655/What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-33/23690/